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Abstract
Phosphatases are essential for the mineralization of the extracellular matrix within the skeleton.
Their precise identities and functions however remain unclear. PHOSPHO1 is a
phosphoethanolamine/phosphocholine phosphatase involved in the generation of inorganic
phosphate for bone mineralization. It is highly expressed at sites of mineralization in bone and
cartilage. The bones of Phospho1−/− mice are hypomineralized, bowed and present with
spontaneous greenstick fractures at birth. In this study we show that PHOSPHO1 is essential for
mechanically competent mineralization that is able to withstand habitual load. Long bones from
Phospho1−/− mice did not fracture during 3- point bending but deformed plastically. With
dynamic loading nanoindentation the elastic modulus and hardness of Phospho1−/− tibiae were
significantly lower than wild-type tibia. Raman microscopy revealed significantly lower
mineral:matrix ratios and lower carbonate substitutions in Phospho1−/− tibia. The altered
dihydroxylysinonorleucine/hydroxyllysinonorleucine and pyridoline/deoxypyridinoline collagen
crosslink ratios indicated possible changes in lysyl hydroxylase-1 activity and/or bone
mineralization status. The bone formation and resorption markers, N-terminal propeptide and C-
terminal telopeptide of Type I collagen, were both increased in Phospho1−/− mice and this we
associated with increased bone remodelling during fracture repair or an attempt to remodel a
mechanically competent bone capable of withstanding physiological load. In summary these data
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indicate that Phospho1−/− bones are hypomineralized and, consequently, are softer and more
flexible. An inability to withstand physiological loading may explain the deformations noted. We
hypothesize that this phenotype is due to the reduced availability of inorganic phosphate to form
hydroxyapatite during mineralization, creating an undermineralized yet active bone.
Keywords
Phospho1; biomineralization; mechanical and material properties; bone quality;
hypomineralization
1 Introduction
During bone growth, formation and development, the mineralization of the extracellular
matrix (ECM) of both chondrocytes and osteoblasts involves the deposition of crystalline
hydroxyapatite (HA) within the interior of membrane-limited matrix-vesicles (MVs) [1–3].
This process is instigated by the accumulation of Ca2+ and inorganic phosphate (Pi) within
MVs resulting in the formation of HA crystals. This initial phase is followed by MV
membrane rupture/breakdown and the modulation of ECM composition to further promote
propagation of HA outside of the MVs [1–3]. ECM mineralization is a highly regulated
process and chondrocytes, osteoblasts and their derived MVs accomplish this by expressing
Pi-transporters for Pi uptake [4–5], annexin V for Ca2+ influx [6] and regulators of inorganic
pyrophosphate (PPi) metabolism [7]. Extracellular PPi is a recognized potent mineralization
inhibitor in biological fluids [8] and its concentration is regulated by tissue-nonspecific
alkaline phosphatase (TNAP) which hydrolyzes PPi in the ECM to establish a Pi/PPi ratio
permissive for the initial formation of HA crystals within MVs [9–12]. Also, nucleotide
pyrophosphatase phosphodiesterase 1 (NPP1) ectoplasmically generates PPi from
nucleoside triphosphates [13], and the multiple-pass transmembrane protein ANK mediates
intracellular to extracellular channelling of PPi [14–15].
In addition to its PPi hydrolase activity, TNAP also has recognized ATPase activity [16] and
disruption of PPi and/or ATP hydrolysis may contribute to hypophosphatasia (HPP), an
inborn error of metabolism resulting in rickets and osteomalacia [17]. Mice deficient in
TNAP function (Akp2−/−) phenocopy infantile HPP i.e. their skeleton at birth is mineralized
normally but hypomineralization rapidly ensues within 1 – 2 weeks of postnatal life before
death at postnatal day 20 [18–19]. The failure of bone to mineralize properly after birth in
Akp2−/− mice has been associated with PPi accumulating within the ECM and blocking the
propagation of HA in the ECM beyond the confines of the MV membrane [20–21]. An
explanation as to why the skeleton of Akp2−/− mice are normally mineralized at birth has
focussed on the existence of other phosphatases responsible for MV-mediated ECM
mineralization and PHOSPHO1 which was identified 10 years ago is a strong candidate for
this missing phosphatase. Since its discovery and characterization [16,22–27] we have
proposed that PHOSPHO1 is, in part, responsible for Pi accumulation (and HA formation)
within the MV through its phosphohydrolase activity towards the membrane phospholipids,
phosphoethanolamine and phosphocholine [26,28]. Consequently, due to its cytosolic
localization and its known presence and activity within MVs [24–25], PHOSPHO1 is likely
to be partly responsible for the intravesicular HA formation noted in MVs derived from HPP
and Akp2−/− chondrocytes and osteoblasts [20–21]. The critical importance of PHOSPHO1
for skeletal mineralization has been recently suggested by the use of small molecule
compounds to inhibit PHOSPHO1 activity in MVs and developing embryonic chick limbs in
vivo [25,27]. Definitive evidence for a mineralization role of PHOSPHO1 was obtained in a
comparison of the bone phenotype of Phospho1−/−, Akp2−/− and Phospho1−/−; Akp2−/−
double knockout mice [29]. The Akp2−/− and Phospho1−/− mice are both characterized by
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lower skeletal mineralization whereas the double ablation of PHOSPHO1 and TNAP leads
to the complete absence of skeletal mineralization. These data are strongly supportive of
independent, non-redundant mechanisms of action of both phosphatases in the
mineralization process [18,29].
Whilst the functional importance of PHOSPHO1 in regulating skeletal mineralization has
now been clearly demonstrated [29] it is still unclear as to how PHOSPHO1 fully
contributes to the maintenance of bone quality and ultimately, bone strength. Our aim was to
analyse the role of PHOSPHO1 during this developmental phase and not at adulthood where
any alterations noted in skeletal integrity may be secondary and a consequence of earlier
developmental cues. Such information is essential if we are to understand fully the
physiological role of PHOSPHO1 in the maintenance of skeletal integrity and explain the
pathological long bone bowing and spontaneous greenstick fractures noted in Phospho1−/−
mice [29]. In this paper we conclusively demonstrate that PHOSPHO1 is essential for the
proper formation of mechanically competent bones able to withstand habitual load.
2 Materials and Methods
2.1 Mice and Tissues
Phospho1-R74X-null mutant (Phospho1−/−) mice were generated by N-ethyl-N-nitrosourea
mutagenesis (ENU) as previously described [29]. We chose to study mice at one month of
age as the skeletal abnormalities previously described by us [29] present immediately after
birth and during juvenile development. For the study of material and mechanical properties
and collagen cross-link analysis, 7 wild-type (WT) and 9 Phospho1−/− 30-day old male mice
were euthanized and their right tibia and right femur were removed and stored in distilled
H2O at −20°C. The left tibia was removed and fixed in 4% paraformaldehyde (PFA) for
static histomorphometric analysis. In further studies, dynamic histomorphometry was
completed in calcein labelled male mice (8 WT and 8 Phospho1−/−). Mice were injected i.p.
with calcein (10 mg/kg in 1.4% w/v NaHCO3) at 19-days and then again at 29 days of age.
Mice were sacrificed at 30 days of age and the left tibia from each mouse was dissected and
processed as described by Rawlinson et al. [30] Blood was collected by cardiac puncture
from 30-day old male mice (14 WT and 16 Phospho1−/−) and serum separated using serum-
clotting-activator tubes (Starstedt Ltd., UK). All animal studies were approved by the
Institutional Animal Users’ Committees of the Sanford-Burnham Medical Research
Institute, La Jolla, CA and The Roslin Institute, UK.
2.2 3-point bending for the determination of bone stiffness and breaking strength
An Instron 5564 materials testing machine (Instron, High Wycombe, UK) fitted with a 2 kN
load cell was used to determine bone stiffness and breaking strength [31]. The span was
fixed at 5.12 mm for femora and at 6.95 mm for tibiae. The cross-head was lowered at 1
mm/min and data were recorded after every 0.2 N change in load and every 0.1 mm change
in deflection. Each bone was tested to fracture. Failure and fracture points were identified
from the load-extension curve as the point of maximum load and where the load rapidly
decreased to zero, respectively. The maximum stiffness was defined as the maximum
gradient of the rising portion of this curve, and the yield point, the point at which the
gradient reduced to 95% of this value. Both values were calculated from a polynomial curve
fitted to the rising region of the load-extension curve in Mathcad (Mathsoft Engineering and
Education Inc., Cambridge, MA, USA).
2.3 Raman microscopy
Raman microscopy and nanoindentation (see below) were conducted on cortical bone
fragments of both tibia and femur after the completion of the 3-point bending analysis. A ~2
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mm transverse section of the diaphyses were analyzed by Raman microscopy as previously
described [32]. The collected data were processed as described by Goodyear et al. [32]
Intensities of bands representing mineral (phosphate v4), matrix (amide III), carbonate and
acid phosphate (HPO4−) were measured and ratios calculated. The full width at half
maximum height of the phosphate symmetric stretching vibration (v1) was measured to
estimate the crystallinity of the bone mineral [33].
2.4 Nanoindentation
Bone slices were embedded in epoxy resin (EPO-SET, MetPrep Ltd, Coventry, UK) for
nanoindentation. The blocks were then grounded using sand paper successively decreasing
grid size closer the diaphyseal cross section was from surface. Once the whole cross-section
was visible at the surface final polishing was done with 5 µm and then 1 µm diamond
suspension and finalized with 0.05 µm γ-alumina slurry (MetPrep Ltd, Coventry, UK).
Nanoindentations were performed using a G200 nanoindenter (Agilent Technologies) fitted
with a Berkovich shaped diamond tip having a Poisson ratio of 0.07 and elastic modulus of
114 GPa. The indenter was controlled with Testworks 4 version 4.10 (MTS System
Corporation) to produce 60 indentations using both quasistatic and dynamic loading
schemes [34]. Indentations for tibiae were done in the anterior-medial aspect of the
transverse diaphyseal bone, while indentations in the femur were done on an anterior
section. Both regions corresponded to areas previously analyzed by Raman microscopy. All
indentations were inspected with a optical microscope (Nikon Eclipse ME600) equipped
with Nomarski optics to remove indentations falling into a pore [35]. Data were processed as
previously described [34,36].
2.5 Biochemical analysis of bone
Representative diaphysial samples of the tibia and femur without cartilaginous remnants
were equilibrated in 0.14M NaCl – 50 mM sodium phosphate, pH 7.5, reduced with
potassium borohydride and finally freeze dried after extensive washing. Weighed samples
were hydrolyzed in 5.7M HCl at 107°C for 20 h. After removal of HCl by evaporation in
vacuo the samples were placed in 1.0 ml water. For measurements of collagen cross-links,
preliminary fractionation of the hydrolysates was performed by partition chromatography
[37] and the components were determined by liquid chromatography/mass spectrometry
using methods similar to those described by Gineyts et al. [38] except that a tandem
instrument (QTRAP® API 4000, Applied Biosystems, Warrington, UK) was used with
specific transitions for each cross-link component. The mature cross-links, pyridinoline
(PYD) and deoxypyridinoline (DPD), and reduced forms of the immature bonds,
dihydroxylysinonorleucine (DHLNL) and hydroxylysinonorleucine (HLNL), were
quantified by reference to standard curves prepared with authentic components.
Hydroxyproline was measured by colorimetric assay according to Firschein and Shill [39],
and the collagen content of bone was calculated assuming each collagen molecule contains
300 residues of hydroxyproline. Calcium was measured using the Jaffe method on a Kone
autoanalyzer and the results expressed in relation to the dry weight of bone and its collagen
content.
2.6 Histomorphometry and dynamic histomorphometry
For static histomorphometry, tibia were fixed in 4% PFA for 24 h, decalcified in 10% EDTA
at 4°C for 21 days, dehydrated using alcohols and embedded in wax using standard
procedures. Longitudinal wax sections (10µm) through the diaphysis and epiphysis were cut
onto ‘Superfrost’ slides (VWR International Ltd, Lutterworth, UK). After dewaxing in
xylene and rehydration in a descending series of alcohols the sections were stained with 1 %
toluidine blue to visualize osteoblasts and reacted for tartrate resistant acid phosphatase
(TRAP) activity using standard methods to visualize osteoclasts. Sections were examined
Huesa et al. Page 4
Bone. Author manuscript; available in PMC 2012 May 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
using a Leitz DMRB microscope and images captured with a Leica DFC300 FX camera at
20X magnification. Images were analyzed using ImageJ and osteoclast number/bone
perimeter (Noc/BPm), osteoclast number/bone area (Noc/BA), osteoblast number/bone
perimeter (Nob/BPm) and osteoblast number/bone area (Nob/BA) were determined in
trabecular bone of the metaphysis. The terminology and units used are those recommended
by the Histomorphometry Nomenclature Committee of the American Society for Bone and
Mineral Research [40]. Dynamic histomorphomtery was done on transverse cryosections
through the mid-diaphysis of each tibiae previously labelled with calcein. Sections were cut
at 15 µm using the CryoJane tape transfer system (Instrumedics, Hackensack, NJ) as
previously described [41]. The sections were imaged with a Zeiss LSM 5 Pascal confocal
microscope and the mineral apposition rate (MAR) was estimated as the distance between
the two labels measured at equidistant points along the perimeter of the cortex and averaged
for each bone.
2.7 Colony forming units (CFUs)
Bone marrow cells were harvested from tibiae of 6 WT and 6 Phospho1−/− 4 week old male
mice and resuspended in α-MEM medium containing 10% FBS, gentamycin (50µg/ml),
100µM ascorbate-2-phosphate and 10 nM dexamethasone. Cells were plated in a six well
plate at a density of 2x106 cells/well. Medium was changed after 5 days and then every 3
days. Cells were maintained in culture for 15 days, reacted for alkaline phosphatase activity
and then the number of colonies formed was counted.
2.8 Biochemical markers of bone turnover
Bone formation and resorption markers were measured in serum from 4-week old WT
(n=16) and Phospho1−/− (n=14) male mice using Rat/Mouse Procollagen type I N-terminal
propeptide (PINP, intra- and inter-assay variation, CV, is 5.0–7.4% and 8.0–9.2%,
respectively) and C-terminal telopeptides of type I collagen (RatLaps™, intra- and inter-
assay variation, CV, is 5.6–9% and 10.5–14.8%, respectively) enzyme immunoassays (IDS,
Boldon, UK), respectively and run according to the manufacturer’s instructions.
2.9 Statistics
All data were checked for normality and equal variance. Unless stated otherwise, normally
distributed data were analyzed using Student’s t-test, while the non-parametric data were
analyzed using a Mann-Whitney Rank Sum test. All analyses were conducted with
SigmaStat software (v 11.0).
3 Results
3.1 The long bones of Phospho1−/− mice do not fracture during 3-point bending
Previous analysis of Phospho1−/− mice revealed reduced accumulation of osteoid in the long
bones, reduced ash mineral content and reduced bone mineral density (BMD) of cortical
bone [29]. Therefore, the consequence of this hypomineralized matrix on the biomechanical
properties of Phospho1−/− bones was first determined. Three-point bending analysis
indicated that the failure load was not statistically different in the tibia (P=0.85) and femur
(P=0.60) between the WT and Phospho1−/− mice (Fig. 1a-d and Suppl. table 1). The
maximum stiffness and yield of the tibia and femur could not be determined in all bones
because the maximum gradient of the load - extension curve occurred at the origin and,
therefore, there was no yield point according to our definition of yield. A function fitted on
the linear region of the load-extension curve also showed no significant differences between
the slope of the WT and Phospho1−/− tibiae (P=0.744) and femora (P=0.516). Despite the
fact that there were no significant differences in the load extension curve until the failure
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point, Phospho1−/− bones did not fracture upon bending and tests were terminated when the
ends of the bone touched the central anvil and the load increased (Figs. 1c and 1d). The rise
at the end of the Phospho1−/− curves is due to impingement on the loading anvils. After
testing, Phospho1−/− bones were very pliable and could be returned to their original shape,
and bent again, still without breaking (Fig. 1e). This was in contrast to the tibia and femur
from the WT mice where fracture did occur in the majority of the bones tested (Figs. 1a and
1b and Suppl. table 1). Some WT bones did not show a fracture point on the load-extension
curve, due to the diaphysis contacting the jig, however, when removed from the testing
machine the bones were fractured. This increased capability for “plastic” deformation
recorded in the Phospho1−/− bones is consistent with the greenstick fractures observed in
the soft bones of the these young mice [29].
3.2 Elasticity and hardness are decreased, while viscosity is increased in Phospho1−/−
bones as determined by nanoindentation
The analysis of the mechanical behaviour of the whole bone as assessed by 3-point bending
was limited by the inability to determine both maximum stiffness and yield and its inherent
limitation to determine only extrinsic properties. To determine the properties at the tissue/
ECM level we next assessed the intrinsic mechanical properties (Table 1) of the WT and
Phospho1−/− femur and tibia by nanoindentation. In comparison to measurements in WT
bones, dynamic testing of the Phospho1−/− tibia indicated that the complex, storage and loss
moduli and plasticity index were significantly decreased by 13.5%, 13.3%, 7.3% (P<0.005)
and 2.6% (P<0.05), respectively, while the loss tangent increased 7.8% (P<0.05). A
quasistatic loading test showed a significant decrease only in the elastic modulus of 10.7%
(P<0.05) within the tibia. Analysis for the curve fitting showed an increase in creep
amplitude A, from 0.032 to 0.036 (12.5%) and decreased early creep strain rate B, from 0.23
to 0.20 (13%) also within the tibia. The response in femora was similar to tibiae but
significant differences were limited due to a decreased storage modulus (7.3%, p<0.05)
between WT and Phospho1−/− mice (Table 1). These data indicate that the tibiae of the
Phospho1−/− mice are softer, more viscous but less elastic and cannot store strain energy as
efficiently as the WT mice. The differences observed between femora and tibiae are not
uncommon and are maybe due to altered loading of the individual long bones of the mouse
hind leg.
3.3 Material properties of Phospho1−/− bones are altered
Bone strength and stiffness are determined by the characteristics of the bone ECM, the
mineral which is formed within it and interactions between the mineral and components of
the matrix. In this way it behaves like a composite material [42]. We therefore next
examined the femora and tibiae of WT and Phospho1−/− mice by Raman microscopy to
determine the composition of the inorganic and organic phases of these bones (Fig. 2).
Tibial bone from Phospho1−/− mice had significantly reduced mineral to matrix (Fig. 2a)
and carbonate to phosphate (Fig. 2b) ratios but an increased relative amount of HPO4− (Fig
2c) compared with WT animals. Similar trends were seen in the femur although only
carbonate/phosphate reached significance. There was no difference in mineral crystallinity,
as determined by the width of the phosphate v1 peak, between the two phenotypes, (Fig. 2d).
These results suggest the ECM of the Phospho1−/− bones was less mineralized and the
mineral itself had a lower concentration of carbonate but more HPO4−.
Collagen fibers within bone are stabilized predominantly by reducible, immature crosslinks
(i.e. measured as their reduced forms hydroxylysinonorleucine (HLNL) and
dehydroxylysinonorleucine (DHLNL)) and non-reducible mature crosslinks (i.e.
pyridinoline, (PYD) and deoxypyridinoline (DPD)), both of which contribute to the
mechanical strength of bone [43]. As expected the young bones analyzed in this study had a
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greater amount of total immature than mature cross-links. There were no differences
between WT and Phospho1−/− mice in the total amount of immature cross-links in either the
tibia or the femur and in the total amount of mature cross-links in the femur, although this
just reached significance in the tibia (Table 2). There were, however significantly higher
DHLNL:HLNL and PYD:DPD ratios in both the tibia and femur of the Phospho1−/− mice
compared with WT bones (Table 2). The Phospho1−/− femur had a greater collagen content
(% dry weight) than the WT femur (P=0.008), which resulted in a lower calcium/collagen
ratio (P=0.008). This pattern was not observed in the tibia (Table 2).
3.4 Phospho1−/− mice have increased cortical bone turnover
In addition to structural and material properties of bone, bone strength and mineralization
status are influenced by the rates of bone formation and bone resorption [44]. The number of
osteoblasts and osteoclasts per bone perimeter (Nob/BPm, Noc/BPm) were similar in both
WT and Phospho1−/− bones as were the number of osteoblasts and osteoclasts per bone area
(Nob/BA, Noc/BA) as measured by histomorphometrical analysis of the trabecular
compartment (Table 3). Calcein labelling of the mid diaphysis of the tibia showed no
significant differences in mineral apposition rate (MAR) between WT and Phospho1−/−
bones (Fig. 3a). Phospho1−/− tibiae were, however, marked by extensive cortical bone
turnover/callus formation regions (Fig. 3b). Five of the 7 Phospho1−/− samples examined
had extensive areas of unorganized “woven-like” bone tissue whereas only 1 of the 6 WT
samples examined (Fig. 3c) showed a similar feature and may be indicative of a repair
mechanism for greenstick or fatigue fractures. Consistent with this increased cortical bone
turnover there were significantly elevated levels of serum bone formation (propeptide of
type I collagen, PINP) and bone resorption (C-terminal telopeptides of type I collagen,
RatLaps™) markers in the Phospho1−/− mice (P<0.001, Fig. 4). In vitro, WT and
Phospho1−/− bone marrow stromal cell cultures produced similar numbers of alkaline
phosphatase positive colony forming units (CFUs, pre- osteoblasts; CFU-AP+, WT 29.1 ±
0.17, Phospho1−/− 23.7 ± 6.99), suggesting that osteoblast differentiation potential in
Phospho1−/− bones was normal.
4 Discussion
The contribution to bone quality of the skeletal-specific phosphatase, PHOSPHO1, is now
emerging [27,29]. When identified over 10 years ago we hypothesized that PHOSPHO1 was
involved in the generation of cytosolic Pi to maintain a Pi/PPi ratio permissive for matrix
mineralization [22]. This premise has been upheld in this and other recent studies in which
the ablation of PHOSPHO1 function in mice results in a number of skeletal abnormalities
that include decreased BMD, osteoidosis and altered geometry and microarchitecture [29] of
the skeletal ECM. It is likely that the altered bone shape and bone architecture reflect
compensatory changes for the lower mineralization status of the Phospho1−/− bones. The
previously observed stockier bones of Phospho1−/− mice [29] provide greater resistance to
bending and torsion loads [45] whereas more trabeculae provide greater support to the
weaker (thinner and more porous) cortex [46–47]. Nevertheless despite these compensatory
structural changes greenstick spontaneous fractures are observed in juvenile Phospho1−/−
mice, as early as day 1, possibly indicating that other determinants of bone strength such as
intrinsic material properties and modelling rates are altered [29]. Moreover, we have an
incomplete picture of how reduced BMD and changes in structural and material integrity
affect the mechanical properties of bone.
Biomechanical analysis of the cortical bone by 3-point bending indicated that, in comparison
with WT bones, the tibia and femur of Phospho1−/− mice displayed plastic deformation
rather than a clean fracture. While this is probably due to the low mineralization status, the
young age of the mice may also contribute. The capacity for greater plastic deformation
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recorded in the Phospho1−/− bones is similar to that seen in the undermineralized bones with
osteomalacia, which are known to be tougher and more ductile [48–49] than healthy bones.
Intrinsic properties of Phospho1−/− ECM behaved as expected based on previously observed
patterns, where a less mineralized matrix is lower in elasticity and softer in nature [34–
35,50], as shown by a smaller storage modulus and larger loss modulus. Bone is a
viscoelastic material where the viscous part of the applied load (energy) is lost as it is
absorbed within ECM, causing permanent changes in bone shape. The elastic part of the
applied load, although also stored within the ECM, is released and the original morphology
is restored upon removal of loading. Thus, the Phospho1−/− bone tissue is more viscous
because it exhibits higher ductility as more energy is used to cause viscous deformations.
The simplest explanation for the increased plasticity of the Phospho1−/− bones is the
reduction in the mineral component of the Phospho1−/− ECM [34,50]. This is in agreement
with our working hypothesis that PHOSPHO1 is a skeletal-specific phosphatase liberating Pi
for HA formation and is consistent with our previous report [29] of reduced ash and BMD in
Phospho1−/− bones and also with the lower phosphate to matrix ratio of Phospho1−/− bones
identified by Raman microscopy in the present study. However, bone strength and
mechanical properties are also influenced by the characteristics of the bone ECM in which
the mineral is embedded and the crystallinity of the mineral itself. The way ECM and
mineral interact is also important for the strength of the composite material [42]. With
ageing, the number of carbonate substitutions in place of phosphate or hydroxyl groups is
known to increase and the relative amount of acid-phosphate (HPO4−) to decrease [51]. The
Raman data, therefore, suggest a younger, less mature matrix, more able to deform without
fracture [52]. A younger matrix is consistent with the increased amount of markers for bone
formation and resorption, indicating an increase in bone turnover.
The major organic component of the bone ECM is collagen type I, which is assembled into
both fibrils and fibres stabilized by cross-links. Collagen cross-links contribute to the
mechanical strength of the bone by influencing both fibril strength and the size and shape of
the regions between the collagen molecules available for crystal deposition [53–55].
However, as the concentration of mature (PYD and DPD) and immature (DHLNL and
HLNL) cross-links were similar in the WT and Phospho1−/− bones it is unlikely that the
altered mechanical properties of the Phospho1−/− bones are due to fewer cross-links. The
most significant alterations in the crosslink profile between the WT and Phospho1−/− bones
were the DHLNL:HLNL and PYD:DPD ratios which are known to influence human
trabecular bone quality [56]. The altered ratios may reflect different degrees of
hydroxylation of specific helical lysine residues by the enzyme lysyl hydroxylase 1 [56–57],
which would lead to a greater proportion of hydroxylysine residues relative to lysine
residues adjacent to the telopeptide aldehydes. Alternatively, it has previously been reported
that the lysyl hydroxylation of tendon collagen type I was reduced on the mineralization of
the tendon suggesting that the low amounts of PYD, and hence lower PYD:DPD ratio
maybe be associated with the mineralization process itself [58]. Therefore it is possible that
the higher PYD:DPD ratio observed in the Phospho1−/− bones may be a consequence of the
hypomineralization of these bones.
As both osteoclast and osteoblast numbers within the trabecular compartment and the
osteoblast differentiation potential (pre- osteoblasts; CFU-AP+) of Phospho1−/− mice were
normal it is unlikely that the increased levels of formation and resorption markers quantified
in the Phospho1−/− serum samples are a result of increased cell number/activity or
osteoblast differentiation potential. It is more plausible that the increased serum bone
markers in Phospho1−/− mice are a result of fracture repair which is secondary to greenstick
fractures that occur in the hypomineralized bone of the Phospho1 −/− mice. [29].
Furthermore the viscoplastic damage noted in the Phospho1−/− bones is likely to be sensed
by the osteocyte [59], triggering bone remodelling and the generation of fracture calluses in
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the Phospho1−/− mice in a similar manner to that reported in greenstick fractures of children
[29,60]. Alternatively the increased PINP and RatLaps™ may reflect an attempt to model
into a mechanically competent bone capable of withstanding physiological load.
In conclusion we have shown in this study that the absence of PHOSPHO1 results in a lower
accumulation of mineral in bones. This leads to differences in bone mineral quantity and
composition and, as a result, the bone is more deformable. This provides an explanation for
the greenstick fractures and the skeletal deformations observed in these mice. We
hypothesize that the poorer quality of the mineral and the lower ECM mineralization induces
an increase in bone turnover as the bone attempts to repair and/or to model itself to create a
mechanically competent bone.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Three point bending load vs extension graphs on 7 WT and 9 Phospho1−/− tibiae and
femora: A) WT tibia, B) Phospho1−/− tibia, C) WT femur and D) Phospho1−/− femur. E)
Representative images of the resilience of a Phospho1−/− tibia after three point bending test.
A Phospho1−/− tibia was straightened after three point bending (left image) and bent again
using callipers (right image).
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Figure 2.
Measurements of material composition on WT and Phospho1−/− cortical bone with Raman
microscopy. A) Phosphate to matrix ratio, B) Carbonate to phosphate ratio, C) Phosphate to
hydrogen phosphate ratio and D) crystallinity. N=5 (WT and Phospho1−/−). Data is shown
as mean ± SD. * P<0.05.
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Figure 3.
Representative observations by dynamic bone histomorphometry in the mid-diaphyses of
WT (N=6) and Phospho1−/− (N=7) tibiae. A) MAR was similar between WT and
Phospho1−/− bones. B) Representative area of callus formation observed in a cortical bone
cross-section of the Phospho1−/− tibia. Unorganized woven-like tissue was frequently noted
in the anterior and posterior regions of the tibial cortex. C) Typical double labelling in WT
tibia cortical bone cross-section indicative of bone growth.
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Figure 4.
Representation of bone turnover markers present in WT (N=16) and Phospho1−/− (N=14)
mice serum as measured with enzyme immunoassays. A) Bone resorption marker
RatLaps™. B) Bone formation marker PINP.
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Table 1
Measurements of mechanical properties at the tissue level by nanoindentation on WT and Phospho1−/−
cortical fragments of tibiae and femora. Measurements: Complex modulus (EC), Storage (EStor), loss (ELoss)
modulus, phase difference (δ), plasticity Index (Ip), both static (HS) and dynamic (HD) hardness, Elastic
modulus (E), overall creep amplitude (ACreep) and early creep strain (BCreep).
Tibia Femur
Dynamic loading WT Phospho1−/− WT Phospho1−/−
EC (GPa) 20.8 ± 1.3b 18.0 ± 1.3 22.0 ± 1.9 20.4 ± 1.3
EStor (GPa) 23.3 ± 1.4b 20.2 ± 1.4 24.6 ± 2.0b 22.8 ± 1.5
ELoss (GPa) 1.79 ± 0.04b 1.66 ± 0.08 1.73 ± 0.08 1.64 ± 0.06
δ 0.077 ± 0.003 a 0.083 ± 0.003 0.071 ± 0.003 0.073 ± 0.005
HS(GPa) 0.79 ± 0.07a 0.70 ± 0.05 0.91 ± 0.10 0.84 ± 0.08
Ip 0.78 ± 0.01a 0.76 ± 0.01 0.77 ± 0.00 0.77 ± 0.01
Quasistatic loading
E (GPa) 20.5 ± 1.4a 18.3 ± 1.9 21.1 ± 1.4 20.3 ± 1.9
HD(GPa) 0.59 ± 0.04 0.56 ± 0.06 0.72 ± 0.09 0.66 ± 0.07
ACreep 0.032 ± 0.011 0.036 ± 0.022 0.023 ± 0.002 0.025 ± 0.002
BCreep 0.23 ± 0.08 0.20 ± 0.08 0.29 ± 0.03 0.28 ± 0.02
a
P<0.05;
b
P<0.01
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Table 2
Measurements of collagen cross links in Phospho1−/− and WT mice cortical bone from tibiae and femora.
Data are shown as mean ± SD unless distribution was not normal, in which case the median is shown.
Abbreviations: Calcium (Ca), pyridinoline (PYD), deoxypyridinoline (DPD), dihydroxylysinonorleucine
(DHLNL) and hydroxylysinonorleucine (HLNL),
Tibia WT Phospho1−/− P value
Collagen 27.4 28.1 0.95
DHLNL 1.233 ± 0.15 1.352 ± 0.12 0.11
HLNL 0.202 0.187 0.029
Total reducible 1.44 ± 0.17 1.55 ± 0.13 0.21
DHLNL:HLNL 5.90 ± 0.49 7.48 ± 0.53 0.001
PYD 0.0329 ± 0.0030 0.0367 ± 0.003 0.026
DPD 0.0214 ± 0.0038 0.0167 ± 0.002 0.012
Total non-reducible 0.0664 ± 0.0077 0.0569 ± 0.009 0.049
PYD:DPD 1.56 ± 0.18 2.18 ± 0.31 0.0004
Collagen (% dry weight) 31.7 ± 7.6 29.0 ± 5.7 0.60
Ca/dry weight (µmol/mg) 5.88 ± 1.5 6.04 ± 0.95 0.90
Ca/collagen (µmol/nmol 6.00 ± 2.4 6.57 ± 1.6 0.81
Femur WT Phospho1−/− P value
Collagen 22.20 ± 1.6 26.4 ± 2.9 0.008
DHLNL 1.49 ± 0.060 1.55 ± 0.19 0.43
HLNL 0.160 0.128 0.029
Total reducible 1.64 ± 0.060 1.69 ± 0.21 0.64
DHLNL:HLNL 9.36 ± 0.723 11.5 ± 1.5 0.008
PYD 0.0444 ± 0.0029 0.0416 ± 0.0051 0.26
DPD 0.0221 ± 0.0049 0.0153 ± 0.0042 0.013
Total non-reducible 0.0543 ± 0.0064 0.0559 ± 0.0042 0.72
PYD:DPD 2.08 ± 0.352 2.84 ± 0.53 0.009
Collagen (% dry weight) 22.2 ± 1.6 26.37 ± 2.9 0.008
Ca/dry weight (µmol/mg) 6.76 ± 0.36 6.034 ± 0.60 0.020
Ca/collagen (µmol/nmol) 9.19 ± 1.1 7.01 ± 1.5 0.008
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Table 3
Measurements from static hystomorphometry. Abbreviations: Number of osteoclasts (Noc), number of
osteoblasts (Nob), bone area (BA) and bone perimeter (BPm).
WT Phospho1−/−
Noc/BA (µm−2) 0.00082 ± 0.00069 0.000874 ± 0.00040
Noc/BPm (µm−1) 0.00784 ± 0.0042 0.0112 ± 0.0018
Nob/BA (µm−2) 0.00365 ± 0.0017 0.00382 ± 0.0015
Nob/BPm (µm−1) 0.0348 ± 0.010 0.0464 ± 0.016
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